DCM
Driehaus Capital Management Portfolio holdings
AUM
$12.5B
1-Year Return
79.21%
This Quarter Return
+34.49%
1 Year Return
+79.21%
3 Year Return
+526.69%
5 Year Return
+1,716.36%
10 Year Return
+17,720.68%
AUM
$12.5B
AUM Growth
+$2.12B
(+20%)
Cap. Flow
+$593M
Cap. Flow
% of AUM
4.74%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
522
New
128
Increased
126
Reduced
142
Closed
106
Top Buys
| 1 |
Credo Technology Group
CRDO
|
+$136M |
| 2 |
HDFC Bank
HDB
|
+$110M |
| 3 |
Astera Labs
ALAB
|
+$104M |
| 4 |
StoneCo
STNE
|
+$100M |
| 5 |
Core Scientific
CORZ
|
+$98.1M |
Top Sells
| 1 |
Yum China
YUMC
|
+$110M |
| 2 |
Sprouts Farmers Market
SFM
|
+$97.6M |
| 3 |
Elastic
ESTC
|
+$78.4M |
| 4 |
Compass
COMP
|
+$71.9M |
| 5 |
Embraer
ERJ
|
+$71.8M |
Sector Composition
| 1 | Technology | 25.59% |
| 2 | Industrials | 19.57% |
| 3 | Healthcare | 18.74% |
| 4 | Financials | 10.53% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Lightbridge
LTBR
$371M
| $5.25M | 0.04% |
+392,984
| New | +$5.25M |
|
|
LUCK
302
Lucky Strike Entertainment Corporation
LUCK
$1.41B
| $5.24M | 0.04% |
574,157
-63,472
| -10% | -$579K |
|
303
Calix
CALX
$3.99B
| $4.94M | 0.04% |
+92,855
| New | +$4.94M |
|
|
CBIO
304
Crescent Biopharma, Inc. Common Stock
CBIO
$180M
| $4.88M | 0.04% |
+302,457
| New | +$4.88M |
|
305
PENN Entertainment
PENN
$2.93B
| $4.88M | 0.04% |
273,088
-45,137
| -14% | -$807K |
|
|
NHIC
306
NewHold Investment Corp III Class A Ordinary shares
NHIC
$281M
| $4.61M | 0.04% |
+453,013
| New | +$4.61M |
|
|
TACO
307
Berto Acquisition Corp. Ordinary Shares
TACO
$385M
| $4.5M | 0.04% |
+431,412
| New | +$4.5M |
|
308
WisdomTree India Earnings Fund ETF
EPI
$2.92B
| $4.33M | 0.03% |
91,206
-661,285
| -88% | -$31.4M |
|
309
KLA
KLAC
$120B
| $4.32M | 0.03% |
4,825
+2,189
| +83% | +$1.96M |
|
310
Lincoln Educational Services
LINC
$619M
| $4.23M | 0.03% |
+183,410
| New | +$4.23M |
|
|
GSHR
311
Gesher Acquisition Corp. II Class A Ordinary Shares
GSHR
| $4.06M | 0.03% |
+400,000
| New | +$4.06M |
|
312
NVIDIA
NVDA
$4.1T
| $3.96M | 0.03% |
25,045
+4,444
| +22% | +$702K |
|
313
CorMedix
CRMD
$952M
| $3.79M | 0.03% |
+307,239
| New | +$3.79M |
|
314
Design Therapeutics
DSGN
$367M
| $3.63M | 0.03% |
1,076,236
+162,837
| +18% | +$549K |
|
315
Microsoft
MSFT
$3.7T
| $3.54M | 0.03% |
7,122
+761
| +12% | +$379K |
|
316
iShares MSCI India ETF
INDA
$9.34B
| $3.39M | 0.03% |
+60,863
| New | +$3.39M |
|
317
Exagen
XGN
$216M
| $3.36M | 0.03% |
480,918
+62,413
| +15% | +$436K |
|
318
BBB Foods
TBBB
$3.03B
| $3.34M | 0.03% |
120,319
-728,847
| -86% | -$20.2M |
|
319
Kellanova
K
$27.6B
| $3.11M | 0.02% |
+39,167
| New | +$3.11M |
|
320
iShares MSCI South Korea ETF
EWY
$5.26B
| $2.74M | 0.02% |
+38,126
| New | +$2.74M |
|
321
Skye Bioscience
SKYE
$128M
| $2.59M | 0.02% |
620,395
| – | – |
|
322
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$636M
| $2.55M | 0.02% |
263,726
| – | – |
|
323
Vista Energy
VIST
$3.65B
| $2.53M | 0.02% |
53,018
-5,160
| -9% | -$247K |
|
324
iShares MSCI Taiwan ETF
EWT
$6.33B
| $2.53M | 0.02% |
+44,113
| New | +$2.53M |
|
325
Vaxcyte
PCVX
$4.21B
| $2.39M | 0.02% |
73,376
-987,487
| -93% | -$32.1M |
|